Agency Forms Undergoing Paperwork Reduction Act Review, 57897-57899 [2024-15535]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 136 / Tuesday, July 16, 2024 / Notices
the advisory committee’s
recommendations; (iii) The types of
specific perspectives required, for
example, such as those of consumers,
technical experts, the public at-large,
academia, business, or other sectors; (iv)
The need to obtain divergent points of
view on the issues before the advisory
committee; and (v) The relevance of
State, local, or tribal governments to the
development of the advisory
committee’s recommendations.
Member Selection Criteria
The following selection criteria will
be used to evaluate nominees.
Committee Members
a. Educational background (e.g.,
degree in business, Information
Technology, law, public policy, or
engineering);
b. Professional experiences and
accomplishments (e.g., projects, nature
of work, or publications);
c. Current employment and
membership in associations or other
activities (e.g., manufacturers, academia,
and civil society organizations); and
d. Subject matter expertise in the key
issue the GAP FAC is examining for the
current period.
e. Willingness to commit time to the
Committee and demonstrated ability to
work constructively and effectively on
committees;
Members will serve one (1) to three
(3) year terms.
khammond on DSKJM1Z7X2PROD with NOTICES
Miscellaneous
The GAP FAC will meet
approximately four times per year. Such
meetings will be open to the public
unless an appropriate authority
determines, in accordance with the
FACA, that a meeting shall be closed or
partially closed. The Committee will
meet virtually with the potential
exception of one in person meeting per
year.
Committee members (including the
Committee Chair) will not be
compensated for their services but will
be allowed travel expenses, including
per diem, in accordance with 5 U.S.C.
5703. Regardless of the type of
committee membership appointment,
any travel expenses shall be paid at
rates equivalent to that allowable to
Federal employees.
Nomination Submissions
Any interested person and/or
organization may nominate qualified
individuals for membership. Individuals
are also encouraged to self-nominate.
The following items must be submitted
in a nomination package:
(1) A letter of nomination stating the
nominee’s name and organizational
VerDate Sep<11>2014
16:55 Jul 15, 2024
Jkt 262001
affiliation(s), nominee’s field of
expertise, specific qualifications to serve
on the Committee, and a brief statement
of interest;
(2) A professional resume or
curriculum vitae (CV); and
(3) A short biography (no more than
two paragraphs) describing the
nominee’s professional and educational
qualifications, including a list of
relevant activities and any current or
previous service on advisory
committees.
The letter of nomination, resume or
CV, and a short biography should
include the candidate’s full name,
address of the current organization,
position title, email address, and
daytime telephone number(s) of the
nominee and nominator.
In preparing the letter of nomination,
please describe how the nominee’s
background, knowledge, and experience
will bring value to the work of the
Committee and how these qualifications
would contribute to the overall diversity
of the Committee. Also, describe any
previous involvement with GSA
through employment, grant funding,
and/or contracting sources, if
applicable.
Nominations are due by August 15,
2024 and must be submitted via email
to: gapfac@gsa.gov.
Jeffrey A. Koses,
Senior Procurement Executive and Acting
Chief Acquisition Officer, Office of
Government-wide Policy, General Services
Administration.
[FR Doc. 2024–15596 Filed 7–15–24; 8:45 am]
BILLING CODE 6820–61–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–24–0199]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Import Permit
Applications (42 CFR 71.54)’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on February 5, 2024 to obtain
comments from the public and affected
agencies. CDC received one comment
related to the previous notice. This
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
57897
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Import Permit Applications (42 CFR
71.54) (OMB Control No. 0920–0199,
Exp. 8/31/2024)—Revision—Office of
Readiness and Response (ORR), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
Section 361 of the Public Health
Service Act (42 U.S.C. 264), as
amended, authorizes the Secretary of
Health and Human Services to make
and enforce such regulations as are
E:\FR\FM\16JYN1.SGM
16JYN1
57898
Federal Register / Vol. 89, No. 136 / Tuesday, July 16, 2024 / Notices
(89 FR 7712) seeking public comments
on ‘‘Application for Permit to Import
Biological Agents and Vectors of Human
Disease into the United States,’’
‘‘Application for Permit to Import or
Transport Live Bats,’’ ‘‘Application for
Permit to Import Infectious Human
Remains into the United States,’’ and
‘‘Importer Certification Statement’’ to
initiate the revision of the information
collection. As a result of this notice,
CDC received one comment that was not
related to the notice or CDC’s Import
Permit Program’s regulatory authority,
therefore, no changes to the data
collection instruments were made.
The Application for Permit to Import
or Transport Live Bats form is used by
laboratory facilities such as those
operated by government agencies,
universities, research institutions, and
for educational, exhibition, or scientific
purposes to request a permit for the
importation, and any subsequent
distribution after importation, of live
bats. This form currently requests the
applicant and sender contact
information; a description and intended
use of bats to be imported; and facility
isolation and containment information.
CDC does not plan to revise this
application.
The Application for Permit to Import
Infectious Human Remains into the
United States is used by facilities that
will bury/cremate the imported cadaver
and educational facilities to request a
permit for the importation and
subsequent transfers throughout the
U.S. of human remains or body parts
that contains biological agents,
infectious substances, or vectors of
human disease. This form will request
applicant and sender contact
necessary to prevent the introduction,
transmission, or spread of
communicable diseases from foreign
countries into the States or possessions,
or from one State or possession into any
other State or possession. Part 71 of title
42, Code of Federal Regulations (Foreign
Quarantine) sets forth provisions to
prevent the introduction, transmission,
and spread of communicable disease
from foreign countries into the United
States. Subpart F—Importations—
contains provisions for the importation
of infectious biological agents,
infectious substances, and vectors (42
CFR 71.54); requiring persons that
import these materials to obtain a
permit issued by the CDC.
The Application for Permit to Import
Biological Agents, Infectious Substances
and Vectors of Human Disease into the
United States form is used by laboratory
facilities, such as those operated by
government agencies, universities, and
research institutions to request a permit
for the importation of biological agents,
infectious substances, or vectors of
human disease. This form currently
requests applicant and sender contact
information; description of material for
importation; facility isolation and
containment information; and personnel
qualifications. Based on questions we
have received from prior applicants,
CDC is proposing to reduce open text
questions and replace them with more
streamlined check boxes. The goal is
that this will clarify what is being asked
of applicants and will increase
efficiency and speed of processing by
reducing back and forth communication
necessary to clarify to applicants.
On February 5, 2024, CDC published
in the Federal Register a 60-day notice
information; facility processing human
remains; cause of death; biosafety and
containment information; and final
destination(s) of imported infectious
human remains. CDC does not plan to
revise this application.
The Importer Certification Statement
is a new form and will be used as an
attestation by an importer stating that
they are importing only noninfectious
biological agent(s) or biological
substance(s). The noninfectious,
imported agent or substance must be
accompanied by an importer
certification statement confirming that
the material is not known to contain or
suspected of containing an infectious
biological agent or has been rendered
noninfectious. This form requests a
detailed description of the material,
statements affirming that the material is
not known or suspected to contain an
infectious biological agent, and one of
the following: (1) How the person
knows that the material does not
contain an infectious biological agent;
(2) Why there is no reason to suspect
that the material contains an infectious
biological agent; or (3) A detailed
description of how the material was
rendered noninfectious.
Annualized burden hours were
calculated based on updated data
obtained from the CDC import permit
database on the number of permits
issued on annual basis since 2021.
There is an increase in burden from 764
hours to 2,044 hours which reflects the
new, proposed form (Importer
Certification Statement) and the
increase in the number of respondents,
to this project. There was no change due
to program changes or adjustments.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Applicants Requesting to Import Biological Agents, Infectious Substances and Vectors.
Application for Permit to Import Biological Agents, Infectious Substances and Vectors of Human Disease
into the United States.
Application for Permit to Import Biological Agents, Infectious Substances and Vectors of Human Disease
into the United States Subsequent Transfer.
Application for a Permit to Import Live Bats ..................
Application for Permit to Import Infectious Human Remains into the United States.
Importer Certification Statement ....................................
Applicants Requesting to Import Biological Agents, Infectious Substances and Vectors.
khammond on DSKJM1Z7X2PROD with NOTICES
Applicants Requesting to Import Live Bats ....................
Applicants Requesting to Import Infectious Human Remains into the United States.
Importer Attestation that the Imported Biological Agent
or Substance is Noninfectious.
VerDate Sep<11>2014
16:55 Jul 15, 2024
Jkt 262001
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Number of
respondents
Type of respondents
E:\FR\FM\16JYN1.SGM
Average
burden per
response
(in hours)
3,300
1
20/60
650
1
10/60
3
3
1
1
20/60
20/60
5,000
1
10/60
16JYN1
57899
Federal Register / Vol. 89, No. 136 / Tuesday, July 16, 2024 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–15535 Filed 7–15–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–24–0493]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘2025 and 2027
National Youth Risk Behavior Survey
(YRBS)’’ to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on February
9, 2024 to obtain comments from the
public and affected agencies. CDC
received one non-substantive comment
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
2025 and 2027 National Youth Risk
Behavior Survey (OMB Control No.
0920–0493)—Reinstatement with
Change—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The purpose of this request is to
obtain OMB approval for a
Reinstatement with Change, of the data
collection titled National Youth Risk
Behavior Survey (YRBS), a school-based
survey that has been conducted
biennially since 1991. OMB approval for
the 2021 YRBS and 2023 YRBS expired
November 30, 2023 (OMB Control No.
0920–0493). CDC seeks a three-year
approval to conduct the YRBS in Spring
2025 and Spring 2027. Changes
incorporated into this Reinstatement
request include the addition of a
validation study of fruit and vegetable
intake, the results of which will be used
to inform changes to the 2027 YRBS
questionnaire. Additional changes
include an updated title for the
information collection to accurately
reflect the years in which the survey
will be conducted and minor changes to
the data collection instrument.
The YRBS assesses priority health risk
behaviors related to the major
preventable causes of mortality,
morbidity, and social problems among
both youth and young adults in the
United States. Data on health risk
behaviors of adolescents are the focus of
approximately 65 national health
objectives in Healthy People 2030, an
initiative of the U.S. Department of
Health and Human Services (HHS). The
YRBS provides data to measure 14
Healthy People 2030 objectives. In
addition, the YRBS can identify racial
and ethnic disparities in health risk
behaviors. No other national source of
data measures as many of the Healthy
People 2030 objectives addressing
adolescent health risk behaviors as the
YRBS. The data also will have
significant implications for policy and
program development for school health
programs nationwide.
In Spring 2025 and Spring 2027, the
YRBS will be conducted among
nationally representative samples of
students attending public and private
schools in grades 9–12, and in 2025, the
validation study will be conducted
among a convenience sample of schools
and students. Information supporting
the YRBS also will be collected from
state-, district-, and school-level
administrators and teachers. The table
below reports the number of
respondents annualized over the threeyear project period. The total estimated
annualized burden hours are 4,389.
There are no costs to respondents other
than their time.
khammond on DSKJM1Z7X2PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
State Administrators ..................
State-level Recruitment Script for the Youth Risk Behavior Survey.
District-level Recruitment Script for the Youth Risk Behavior Survey.
School-level Recruitment Script for the Youth Risk Behavior Survey.
School-level Recruitment Script for the Validation Study
District Administrators ................
School Administrators ................
School Administrators ................
VerDate Sep<11>2014
16:55 Jul 15, 2024
Jkt 262001
PO 00000
Frm 00057
Fmt 4703
Number of
responses per
respondent
Number of
respondents
Type of respondent
Sfmt 4703
E:\FR\FM\16JYN1.SGM
Average
burden per
response
(in hr)
17
1
30/60
80
1
30/60
133
1
30/60
6
1
30/60
16JYN1
]]>Agencies
[Federal Register Volume 89, Number 136 (Tuesday, July 16, 2024)]
[Notices]
[Pages 57897-57899]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-15535]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-24-0199]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Import Permit Applications (42 CFR 71.54)''
to the Office of Management and Budget (OMB) for review and approval.
CDC previously published a ``Proposed Data Collection Submitted for
Public Comment and Recommendations'' notice on February 5, 2024 to
obtain comments from the public and affected agencies. CDC received one
comment related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Import Permit Applications (42 CFR 71.54) (OMB Control No. 0920-
0199, Exp. 8/31/2024)--Revision--Office of Readiness and Response
(ORR), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Section 361 of the Public Health Service Act (42 U.S.C. 264), as
amended, authorizes the Secretary of Health and Human Services to make
and enforce such regulations as are
[[Page 57898]]
necessary to prevent the introduction, transmission, or spread of
communicable diseases from foreign countries into the States or
possessions, or from one State or possession into any other State or
possession. Part 71 of title 42, Code of Federal Regulations (Foreign
Quarantine) sets forth provisions to prevent the introduction,
transmission, and spread of communicable disease from foreign countries
into the United States. Subpart F--Importations--contains provisions
for the importation of infectious biological agents, infectious
substances, and vectors (42 CFR 71.54); requiring persons that import
these materials to obtain a permit issued by the CDC.
The Application for Permit to Import Biological Agents, Infectious
Substances and Vectors of Human Disease into the United States form is
used by laboratory facilities, such as those operated by government
agencies, universities, and research institutions to request a permit
for the importation of biological agents, infectious substances, or
vectors of human disease. This form currently requests applicant and
sender contact information; description of material for importation;
facility isolation and containment information; and personnel
qualifications. Based on questions we have received from prior
applicants, CDC is proposing to reduce open text questions and replace
them with more streamlined check boxes. The goal is that this will
clarify what is being asked of applicants and will increase efficiency
and speed of processing by reducing back and forth communication
necessary to clarify to applicants.
On February 5, 2024, CDC published in the Federal Register a 60-day
notice (89 FR 7712) seeking public comments on ``Application for Permit
to Import Biological Agents and Vectors of Human Disease into the
United States,'' ``Application for Permit to Import or Transport Live
Bats,'' ``Application for Permit to Import Infectious Human Remains
into the United States,'' and ``Importer Certification Statement'' to
initiate the revision of the information collection. As a result of
this notice, CDC received one comment that was not related to the
notice or CDC's Import Permit Program's regulatory authority,
therefore, no changes to the data collection instruments were made.
The Application for Permit to Import or Transport Live Bats form is
used by laboratory facilities such as those operated by government
agencies, universities, research institutions, and for educational,
exhibition, or scientific purposes to request a permit for the
importation, and any subsequent distribution after importation, of live
bats. This form currently requests the applicant and sender contact
information; a description and intended use of bats to be imported; and
facility isolation and containment information. CDC does not plan to
revise this application.
The Application for Permit to Import Infectious Human Remains into
the United States is used by facilities that will bury/cremate the
imported cadaver and educational facilities to request a permit for the
importation and subsequent transfers throughout the U.S. of human
remains or body parts that contains biological agents, infectious
substances, or vectors of human disease. This form will request
applicant and sender contact information; facility processing human
remains; cause of death; biosafety and containment information; and
final destination(s) of imported infectious human remains. CDC does not
plan to revise this application.
The Importer Certification Statement is a new form and will be used
as an attestation by an importer stating that they are importing only
noninfectious biological agent(s) or biological substance(s). The
noninfectious, imported agent or substance must be accompanied by an
importer certification statement confirming that the material is not
known to contain or suspected of containing an infectious biological
agent or has been rendered noninfectious. This form requests a detailed
description of the material, statements affirming that the material is
not known or suspected to contain an infectious biological agent, and
one of the following: (1) How the person knows that the material does
not contain an infectious biological agent; (2) Why there is no reason
to suspect that the material contains an infectious biological agent;
or (3) A detailed description of how the material was rendered
noninfectious.
Annualized burden hours were calculated based on updated data
obtained from the CDC import permit database on the number of permits
issued on annual basis since 2021. There is an increase in burden from
764 hours to 2,044 hours which reflects the new, proposed form
(Importer Certification Statement) and the increase in the number of
respondents, to this project. There was no change due to program
changes or adjustments.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Applicants Requesting to Import Application for Permit 3,300 1 20/60
Biological Agents, Infectious to Import Biological
Substances and Vectors. Agents, Infectious
Substances and Vectors
of Human Disease into
the United States.
Applicants Requesting to Import Application for Permit 650 1 10/60
Biological Agents, Infectious to Import Biological
Substances and Vectors. Agents, Infectious
Substances and Vectors
of Human Disease into
the United States
Subsequent Transfer.
Applicants Requesting to Import Live Application for a Permit 3 1 20/60
Bats. to Import Live Bats.
Applicants Requesting to Import Application for Permit 3 1 20/60
Infectious Human Remains into the to Import Infectious
United States. Human Remains into the
United States.
Importer Attestation that the Importer Certification 5,000 1 10/60
Imported Biological Agent or Statement.
Substance is Noninfectious.
----------------------------------------------------------------------------------------------------------------
[[Page 57899]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-15535 Filed 7-15-24; 8:45 am]
BILLING CODE 4163-18-P
